Literature DB >> 606433

Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.

D J Bradley, J Kirkley.   

Abstract

The course of infection with Leishmania donovani was followed in seven strains of laboratory mice with measurement of the liver parasite burdens over 20 weeks. The acute parasite population growth rate varied greatly between, but not within, strains. Four strains were relatively resistant with less than an eight-fold increase while the three acutely susceptible strains showed over an eight-fold increase in the first month. Thereafter, one initially susceptible strain showed a dramatic fall in parasite numbers with histological liver damage while another strain maintained an immense parasite load for up to 2 years involving mononuclear phagocytes throughout the body. The system provides a model for studying genetic control of resistance to intracellular infection and the range of responses is compared with human leprosy and cutaneous leishmaniasis.

Entities:  

Mesh:

Year:  1977        PMID: 606433      PMCID: PMC1541173     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  The Giemsa-colophonium method for staining protozoa in tissue sections.

Authors:  R S BRAY; P C GARNHAM
Journal:  Indian J Malariol       Date:  1962-06

2.  COMPETITIVE RELATIONSHIP BETWEEN EPERYTHROZOON COCCOIDES AND PLASMODIUM BERGHEI IN THE MOUSE.

Authors:  W PETERS
Journal:  Exp Parasitol       Date:  1965-04       Impact factor: 2.011

3.  [Experimental leishmaniasis in the mouse (Leishmania donovani and Leishmania tropica)].

Authors:  E PHILIPPE; A CHADLI
Journal:  Arch Inst Pasteur Tunis       Date:  1961-12

4.  Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica.

Authors:  P M Preston; R L Carter; E Leuchars; A J Davies; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

5.  Immunity in cutaneous leishmaniasis of the guinea-pig.

Authors:  A D Bryceson; R S Bray; R A Wolstencroft; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

6.  Some observations on chronic visceral leishmaniasis of the mouse.

Authors:  D J Bradley; J C Poole; R M Lamb
Journal:  Trans R Soc Trop Med Hyg       Date:  1973       Impact factor: 2.184

7.  Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease.

Authors:  A D Bryceson
Journal:  Trans R Soc Trop Med Hyg       Date:  1969       Impact factor: 2.184

Review 8.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

9.  Eperythrozoon coccoides: influence on course of infection of Plasmodium chabaudi in mouse.

Authors:  K J Ott; L A Stauber
Journal:  Science       Date:  1967-03-24       Impact factor: 47.728

  9 in total
  92 in total

1.  The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis.

Authors:  Susan Wyllie; Stephen Patterson; Laste Stojanovski; Frederick R C Simeons; Suzanne Norval; Robert Kime; Kevin D Read; Alan H Fairlamb
Journal:  Sci Transl Med       Date:  2012-02-01       Impact factor: 17.956

2.  In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.

Authors:  Karin Seifert; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Demonstration of acquired resistance in Bcgr inbred mouse strains infected with a low dose of BCG montreal.

Authors:  I M Orme; F M Collins
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

4.  3'-Deoxy-3'-fluoroinosine as a potent antileishmanial agent. The metabolism and selective cytotoxic effect of 3'-deoxy-3'-fluoroinosine against Leishmania tropica and L. donovani in vitro and in vivo.

Authors:  I S Shin; H Tanifuji; Y Arata; Y Morizawa; T Nakayama; Y Wataya
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

5.  Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine in murine model of visceral leishmaniasis.

Authors:  Tejinder Kaur; Ankita Thakur; Sukhbir Kaur
Journal:  J Parasit Dis       Date:  2012-09-06

Review 6.  Genetics-squared: combining host and pathogen genetics in the analysis of innate immunity and bacterial virulence.

Authors:  Jenny Persson; Russell E Vance
Journal:  Immunogenetics       Date:  2007-09-14       Impact factor: 2.846

7.  Production of hybrids of mouse myeloma cells and protozoa which express parasite antigens.

Authors:  M H Rodriguez-Lopez; P R Crocker; T J Harrison; G A Targett; D J Bradley
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

8.  Transfer of innate resistance and susceptibility to Leishmania donovani infection in mouse radiation bone marrow chimaeras.

Authors:  P R Crocker; J M Blackwell; D J Bradley
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

9.  The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Authors:  Susanna S Ng; Fabian De Labastida Rivera; Juming Yan; Dillon Corvino; Indrajit Das; Ping Zhang; Rachel Kuns; Shashi Bhushan Chauhan; Jiajie Hou; Xian-Yang Li; Teija C M Frame; Benjamin A McEnroe; Eilish Moore; Jinrui Na; Jessica A Engel; Megan S F Soon; Bhawana Singh; Andrew J Kueh; Marco J Herold; Marcela Montes de Oca; Siddharth Sankar Singh; Patrick T Bunn; Amy Roman Aguilera; Mika Casey; Matthias Braun; Nazanin Ghazanfari; Shivangi Wani; Yulin Wang; Fiona H Amante; Chelsea L Edwards; Ashraful Haque; William C Dougall; Om Prakash Singh; Alan G Baxter; Michele W L Teng; Alex Loukas; Norelle L Daly; Nicole Cloonan; Mariapia A Degli-Esposti; Jude Uzonna; William R Heath; Tobias Bald; Siok-Keen Tey; Kyohei Nakamura; Geoffrey R Hill; Rajiv Kumar; Shyam Sundar; Mark J Smyth; Christian R Engwerda
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 25.606

10.  Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals.

Authors:  J Nieto; J Alvar; A B Mullen; K C Carter; C Rodríguez; M I San Andrés; M D San Andrés; A J Baillie; F González
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.